- Home
- CHRS vs GGR Comparison
CHRS vs GGR Comparison
Compare CHRS & GGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- GGR
- Stock Information
- Founded
- CHRS 2010
- GGR 2011
- Country
- CHRS United States
- GGR Taiwan
- Employees
- CHRS 177
- GGR N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- GGR Auto Manufacturing
- Sector
- CHRS Health Care
- GGR Consumer Discretionary
- Exchange
- CHRS Nasdaq
- GGR Nasdaq
- Market Cap
- CHRS 149.9M
- GGR 101.1M
- IPO Year
- CHRS 2014
- GGR N/A
- Fundamental
- Price
- CHRS $1.37
- GGR $0.35
- Analyst Decision
- CHRS Strong Buy
- GGR Hold
- Analyst Count
- CHRS 4
- GGR 2
- Target Price
- CHRS $4.51
- GGR $0.50
- AVG Volume (30 Days)
- CHRS 1.4M
- GGR 206.4K
- Earning Date
- CHRS 11-05-2025
- GGR 08-12-2025
- Dividend Yield
- CHRS N/A
- GGR N/A
- EPS Growth
- CHRS N/A
- GGR N/A
- EPS
- CHRS 1.55
- GGR N/A
- Revenue
- CHRS $272,209,000.00
- GGR $289,420,000.00
- Revenue This Year
- CHRS N/A
- GGR N/A
- Revenue Next Year
- CHRS $126.00
- GGR $5.00
- P/E Ratio
- CHRS $0.88
- GGR N/A
- Revenue Growth
- CHRS 52.33
- GGR N/A
- 52 Week Low
- CHRS $0.66
- GGR $0.19
- 52 Week High
- CHRS $2.43
- GGR $1.13
- Technical
- Relative Strength Index (RSI)
- CHRS 73.83
- GGR 48.70
- Support Level
- CHRS $1.26
- GGR $0.34
- Resistance Level
- CHRS $1.39
- GGR $0.37
- Average True Range (ATR)
- CHRS 0.08
- GGR 0.02
- MACD
- CHRS 0.02
- GGR -0.00
- Stochastic Oscillator
- CHRS 94.10
- GGR 45.21
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About GGR Gogoro Inc.
Gogoro Inc is focused on eliminating the barriers to electric fuel adoption to bring swappable electric power within reach of every urban rider. Its battery swapping technology compromises an interoperable platform that seamlessly integrates a comprehensive ecosystem of hardware, software, and services, which consists of Gogoro Smart Batteries, GoStations, Gogoro Network Software & Battery Management Systems, Smartscooter, and related components and kits. Geographical presence in Taiwan and Other countries, majority of its revenue comes from Tiwan.